查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539675

內分泌胜肽檢測2024年全球市場報告

Endocrine Peptide Test Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

內分泌胜肽檢測市場規模預計在未來幾年將強勁成長。 2028年將以9.4%的年複合成長率（CAGR）成長至130.3億美元。預測期內的成長是由於內分泌胜肽檢測需求的增加、研發的擴大、文明病的增加、老年人口的迅速增加以及普通人群中糖尿病患病率的上升。預計這段時期的主要趨勢包括內分泌檢測方法的進步、產品技術的改進、旨在開發創新檢測解決方案的研發活動的活性化、產品核可的增加以及對預防性醫療保健的關注度的增加等。

糖尿病盛行率的增加預計將推動內分泌胜肽檢測市場的成長。糖尿病以血糖值升高為特徵，由於不良的飲食習慣、久坐的生活方式、遺傳傾向和衰老等因素，糖尿病的發生率正在上升。血紅蛋白 A1c、空腹血糖和 C胜肽測試等內分泌胜肽測試在診斷糖尿病、監測血糖濃度以及評估胰島素產生和敏感性方面發揮重要作用。例如，2021年，國際糖尿病聯盟報告稱，全球約有5.37億20歲至79歲的成年人患有糖尿病。預計到 2030 年，這一數字將增至 6.43 億，到 2045 年將增至 7.83 億，凸顯了糖尿病盛行率驅動的市場成長軌跡。

內分泌胜肽檢測市場的主要企業正在開發提高準確性、靈敏度和速度的免疫檢測檢測系統。這些系統使用抗體來檢測和量化血液和尿液樣本中的特定勝胜肽，為醫療保健專業人員提供有關荷爾蒙水平和內分泌功能的重要見解。例如，2023 年 7 月，西門子 Healthineers 推出了 Atellica CI 分析儀，這是一種緊湊型系統，能夠進行免疫測量和臨床化學測試，包括內分泌胜肽測定。我們的生殖內分泌菜單包括用於評估卵巢儲備功能的抗苗勒氏管激素 (AMH) 以及用於妊娠毒血症預後的 sFlt-1 和 PlGF 等測試。 Atellica CI 分析儀每小時能夠進行多達 1000 次測試，可提供快速、一致、高品質的結果，幫助實驗室滿足不斷變化的測試需求。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球內分泌勝胜肽檢測市場：促進因素與抑制因素
    • 市場促進因素
    • 市場限制因素
  • 全球內分泌胜肽檢測市場表現：規模和成長，2018-2023
  • 全球內分泌勝胜肽檢測市場預測：規模與成長，2023-2028、2033

第6章 市場細分

  • 全球內分泌勝胜肽檢測市場：依檢測類型分類的表現與預測，2018-2023、2023-2028、2033
  • 硫酸脫氫表雄酮
  • 黃體酮
  • 黃體激素
  • 甲狀腺催乳素
  • 雌二醇
  • 人類絨毛膜促性腺激素分泌
  • 甲狀腺刺激素
  • 其他測試類型
  • 全球內分泌勝胜肽檢測市場：依技術、效能和預測分類，2018-2023年、2023-2028年、2033年
  • 質譜分析
  • 免疫檢測
  • 層析法
  • 基於核酸的
  • 其他技術
  • 全球內分泌胜肽檢測市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 診所
  • 保健中心
  • 醫院
  • 商業研究所

第 7 章 區域/國家分析

  • 全球內分泌勝胜肽檢測市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球內分泌勝胜肽檢測市場：依國家、績效及預測，2018-2023年、2023-2028年、2033年

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 內分泌勝胜肽檢測市場：競爭格局
  • 內分泌勝胜肽檢測市場：公司簡介
    • Siemens AG
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Becton Dickinson and Company

第31章 其他重大及創新企業

  • Laboratory Corporation of America Holdings（LabCorp）
  • Quest Diagnostics Incorporated
  • Agilent Technologies Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Sciex
  • Bio-Techne Corporation
  • Invitae Corporation
  • ARUP Laboratories
  • Genova Diagnostics
  • Boston Heart Diagnostics Corporation
  • Immunodiagnostic Systems Ltd.
  • Mayo Clinic Laboratories

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r19114

The endocrine peptide test is a diagnostic procedure used to assess levels of specific peptides in blood or urine, crucial for monitoring the endocrine system's function and detecting related disorders. It primarily focuses on measuring peptide hormones in blood to diagnose and track endocrine disorders.

Key tests in the endocrine peptide market include dehydroepiandrosterone sulfate (DHEAS), progesterone, luteinizing hormone, thyroid prolactin, estradiol, human chorionic gonadotropin, thyroid-stimulating hormone, among others. The DHEAS test specifically measures DHEAS levels in the bloodstream. Technologies employed include mass spectroscopy, immunoassay, chromatography, nucleic acid-based methods, and others. End users include clinics, healthcare centers, hospitals, and commercial laboratories.

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The endocrine peptide test market size has grown strongly in recent years. It will grow from $8.34 billion in 2023 to $9.11 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The increase during the historic period was driven by higher government expenditure, a growing incidence of diabetes, declining immunity levels globally, heightened risk of chronic diseases, and increased governmental initiatives.

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $13.03 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. Anticipated growth in the forecast period will stem from rising demand for endocrine peptide tests, expansion in research and development efforts, an uptick in lifestyle diseases, a burgeoning elderly population, and a rising prevalence of diabetes among the general populace. Key trends expected in this period include advancements in endocrine testing methodologies, improvements in product technologies, increased R&D activities aimed at developing innovative testing solutions, a rise in product approvals, and a shift towards preventive healthcare.

The increasing prevalence of diabetes is expected to drive growth in the endocrine peptide test market. Diabetes, characterized by elevated blood sugar levels, is on the rise due to factors such as poor diets, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine peptide tests such as hemoglobin A1c, fasting plasma glucose, and C-peptide tests play a crucial role in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For instance, in 2021, the International Diabetes Federation reported that approximately 537 million adults aged 20-79 were living with diabetes globally. This number is projected to increase to 643 million by 2030 and 783 million by 2045, highlighting the market's growth trajectory driven by diabetes prevalence.

Leading companies in the endocrine peptide test market are advancing immunoassay testing systems to enhance accuracy, sensitivity, and speed. These systems employ antibodies to detect and quantify specific peptides in blood or urine samples, providing healthcare professionals with essential insights into hormone levels and endocrine function. For example, Siemens Healthineers introduced the Atellica CI Analyzer in July 2023, a compact system capable of immunoassay and clinical chemistry testing, including endocrine peptide assays. It features a reproductive endocrinology menu with tests such as anti-Mullerian hormone (AMH) for ovarian reserve assessment and sFlt-1 and PlGF for preeclampsia prognosis. With a capacity of up to 1000 tests per hour, the Atellica CI Analyzer ensures rapid and consistent delivery of high-quality results, supporting laboratories in meeting evolving testing demands.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics to bolster its portfolio in pediatric endocrinology and men's health. Jatenzo, a testosterone replacement therapy, complements Tolmar's specialty pharmaceutical products, enhancing their offerings for individuals with endocrine disorders. Clarus Therapeutics, known for developing therapies in this field, facilitated the acquisition, expanding Tolmar's market presence and therapeutic capabilities.

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

North America was the largest region in the endocrine peptide test market in 2023. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Peptide Test Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine peptide test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine peptide test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine peptide test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test-Type: Dehydroepiandrosterone Sulphate; Progesterone; Luteinizing Hormone; Thyroid Prolactin; Oestradiol; Human Chorionic Gonadotropin; Thyroid-Stimulating Hormone; Other Test-Types
  • 2) By Technology: Mass Spectroscopy; Immunoassay; Chromatography; Nucleic Acid Based; Other Technologies
  • 3) By End-User: Clinics; Healthcare Centers; Hospitals; Commercial Laboratories
  • Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Peptide Test Market Characteristics

3. Endocrine Peptide Test Market Trends And Strategies

4. Endocrine Peptide Test Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Endocrine Peptide Test Market Size and Growth

  • 5.1. Global Endocrine Peptide Test Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Endocrine Peptide Test Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Endocrine Peptide Test Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Endocrine Peptide Test Market Segmentation

  • 6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dehydroepiandrosterone Sulphate
  • Progesterone
  • Luteinizing Hormone
  • Thyroid Prolactin
  • Oestradiol
  • Human Chorionic Gonadotropin
  • Thyroid-Stimulating Hormone
  • Other Test-Types
  • 6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Mass Spectroscopy
  • Immunoassay
  • Chromatography
  • Nucleic Acid Based
  • Other Technologies
  • 6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinics
  • Healthcare Centers
  • Hospitals
  • Commercial Laboratories

7. Endocrine Peptide Test Market Regional And Country Analysis

  • 7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Endocrine Peptide Test Market

  • 8.1. Asia-Pacific Endocrine Peptide Test Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Endocrine Peptide Test Market

  • 9.1. China Endocrine Peptide Test Market Overview
  • 9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Endocrine Peptide Test Market

  • 10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Endocrine Peptide Test Market

  • 11.1. Japan Endocrine Peptide Test Market Overview
  • 11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Endocrine Peptide Test Market

  • 12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Endocrine Peptide Test Market

  • 13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Endocrine Peptide Test Market

  • 14.1. South Korea Endocrine Peptide Test Market Overview
  • 14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Endocrine Peptide Test Market

  • 15.1. Western Europe Endocrine Peptide Test Market Overview
  • 15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Endocrine Peptide Test Market

  • 16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Endocrine Peptide Test Market

  • 17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Endocrine Peptide Test Market

  • 18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Endocrine Peptide Test Market

  • 19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Endocrine Peptide Test Market

  • 20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Endocrine Peptide Test Market

  • 21.1. Eastern Europe Endocrine Peptide Test Market Overview
  • 21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Endocrine Peptide Test Market

  • 22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Endocrine Peptide Test Market

  • 23.1. North America Endocrine Peptide Test Market Overview
  • 23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Endocrine Peptide Test Market

  • 24.1. USA Endocrine Peptide Test Market Overview
  • 24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Endocrine Peptide Test Market

  • 25.1. Canada Endocrine Peptide Test Market Overview
  • 25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Endocrine Peptide Test Market

  • 26.1. South America Endocrine Peptide Test Market Overview
  • 26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Endocrine Peptide Test Market

  • 27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Endocrine Peptide Test Market

  • 28.1. Middle East Endocrine Peptide Test Market Overview
  • 28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Endocrine Peptide Test Market

  • 29.1. Africa Endocrine Peptide Test Market Overview
  • 29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Peptide Test Market Competitive Landscape
  • 30.2. Endocrine Peptide Test Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Endocrine Peptide Test Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings (LabCorp)
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Agilent Technologies Inc.
  • 31.4. Illumina Inc.
  • 31.5. bioMerieux SA
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Sciex
  • 31.9. Bio-Techne Corporation
  • 31.10. Invitae Corporation
  • 31.11. ARUP Laboratories
  • 31.12. Genova Diagnostics
  • 31.13. Boston Heart Diagnostics Corporation
  • 31.14. Immunodiagnostic Systems Ltd.
  • 31.15. Mayo Clinic Laboratories

32. Global Endocrine Peptide Test Market Competitive Benchmarking

33. Global Endocrine Peptide Test Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

35. Endocrine Peptide Test Market Future Outlook and Potential Analysis

  • 35.1 Endocrine Peptide Test Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Peptide Test Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Peptide Test Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer